ClinicalTrials.Veeva

Menu

Correlation Between Clinical Deterioration in Schizophrenic Patients and Hair Cortisol Levels

S

Shalvata Mental Health Center

Status

Completed

Conditions

Schizophrenia
Schizo-Affective Disorder

Treatments

Biological: Hair Sample

Study type

Observational

Funder types

Other

Identifiers

NCT01754532
SHA-12-0028

Details and patient eligibility

About

The importance of stress as a possible deteriorating factor for schizophrenic patients is well documented. However, this notion is based on subjective experience and retrospective psychological analysis.

A novel method of measuring cortisol using hair has a proven correlation to subjective stress in non-clinical as well as psychiatric clinical populations.

This pilot study will attempt to assess the use of cortisol hair level, as a marker of stress, to predict clinical deterioration in schizophrenic patients.

Enrollment

34 patients

Sex

All

Ages

18 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 18-50
  • Diagnosis of schizophrenia or schizoaffective disorder, made by a senior psychiatrist.
  • Signing an informed consent.

Exclusion criteria

  • Additional psychiatric diagnosis
  • Boldness or hair shorter than 1cm
  • Physiological disturbance in the HPA or the use of steroidal medication
  • Neurological disease (past or present) or neurosurgery.
  • Pregnancy
  • Substantial chronic physical diseases/

Trial design

34 participants in 1 patient group

Schizophrenia patients
Treatment:
Biological: Hair Sample

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems